Tokyo, Aug. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062519) titled 'A Registry Study of Patients with Cardiac Implantable Electronic Devices' on Aug. 7.
Study Type:
Observational
Primary Sponsor:
Institute - Juntendo University
Condition:
Condition - Inpatients and outpatients with cardiac implantable electronic devices (pacemakers, ICDs, CRT-Ps, CRT-Ds)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the prevalence of heart failure (particularly HFpEF) in patients with cardiac implantable electronic devices, overall prognosis, and long-term outcomes of conduction system pacing (CSP)
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with implanted pacemakers (transvenous, leadless), ICDs, CRT-P devices or CRT-D devices
Key exclusion criteria - Severe organic valvular heart disease
Serious complications (malignant diseases with a predicted prognosis of less than one year, severe chronic obstructive pulmonary disease, haemodialysis)
Pregnancy
Any other patients deemed unsuitable as study participants by the principal investigator or co-investigators
Target Size - 550
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2026 Year 05 Month 29 Day
Date of IRB - 2026 Year 07 Month 28 Day
Anticipated trial start date - 2026 Year 08 Month 07 Day
Last follow-up date - 2032 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071566
Disclaimer: Curated by HT Syndication.
